The clinical trial aims to create a safe network of domed Microcities that can house up to one million people, prioritizing veteran housing and medical care, and is supported by Veterans Recovery Network and the AI-119 Vulcan PRETCO.

The project is linked to an NIH clinical trial (PRIS:NCT07661823) testing safe human-AI collaboration in Microcities, each housing 1,500 to 15,000 occupants.

A broader NIH trial focuses on safe human-AI collaboration with a specific emphasis on veterans' housing and medical care within these communities.

Public statements compare QAIAx credentials to historic IT certifications, but for supervising self-running systems rather than configuring hardware.

Privacy, security, and regulatory compliance are core pillars of the system, designed to align with federal laws.

The system claims advanced safety and privacy controls surpassing 1990s security practices, including data minimization, anonymous identifiers, and opt-out rights for human doctors instead of letting AI make decisions.

The rollout references multiple related press materials and a press room image, signaling coordinated communications around the initiative.

The QAIA Pro License would certify professionals—such as attorneys and doctors—after a 220-hour training super-class to supervise AI operations within the Microcities.

A mandatory QAIA Pro License is earned by completing a 220-hour program, enabling professionals to operate within the QAIAx clinical trial network.

The QAIA Pro License program is described as a modern parallel to 1980s/1990s network certifications, tailored for AI-managed cities.

A patent application for the QAIAx TDC Model Code establishes a safety framework and certification for managing AI-enabled microcities.

A July 5, 2026 press release announces the patent application for QAIAx TDC Model Code, to govern safety and human oversight in the microcity AI ecosystem.